BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2341 related articles for article (PubMed ID: 2986378)

  • 1. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The five human herpesviruses: infection, prevention, and treatment.
    Galasso GJ; Myers MW
    Adv Intern Med; 1984; 29():25-58. PubMed ID: 6324554
    [No Abstract]   [Full Text] [Related]  

  • 3. [Herpes virus infections in immunosuppressed patients. Herpes simplex and varicella zoster virus: prevention and therapy].
    Mertens T
    Fortschr Med; 1989 Aug; 107(25):537-40. PubMed ID: 2553562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
    Sundin M; Orvell C; Rasmusson I; Sundberg B; Ringdén O; Le Blanc K
    Bone Marrow Transplant; 2006 Jun; 37(11):1051-9. PubMed ID: 16604097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
    Engelmann I; Petzold DR; Kosinska A; Hepkema BG; Schulz TF; Heim A
    J Med Virol; 2008 Mar; 80(3):467-77. PubMed ID: 18205230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human herpesvirus 6 (HHV-6): incidence in healthy blood donors and in patients with acute infections caused by other herpes viruses].
    Larcher C; Huemer HP; Hönlinger M; Margreiter R; Dierich MP
    Wien Klin Wochenschr; 1989 Jun; 101(13):448-50. PubMed ID: 2548350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral manifestations of viral infections in immunocompromised patients.
    Schubert MM
    Curr Opin Dent; 1991 Aug; 1(4):384-97. PubMed ID: 1666308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir and other chemotherapy for herpes group viral infections.
    Balfour HH
    Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical picture of Herpesviridae infections among immunocompromised patients: bone marrow and solid organ transplants recipients].
    Simon K; Dziemianko I
    Przegl Epidemiol; 2003; 57(2):289-97. PubMed ID: 12910597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes virus infections: clinical manifestations and therapeutic strategies in immunocompromised patients.
    Saral R; Burns WH; Prentice HG
    Clin Haematol; 1984 Oct; 13(3):645-60. PubMed ID: 6094062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesvirus infection in man.
    Zachariae H
    Scand J Infect Dis Suppl; 1985; 47():44-50. PubMed ID: 3006233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
    Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF
    Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesvirus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). How to use ganciclovir (DHPG) and acyclovir.
    Drew WL; Buhles W; Erlich KS
    Infect Dis Clin North Am; 1988 Jun; 2(2):495-509. PubMed ID: 2849621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiviral prophylaxis].
    Graubner UB
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic antivirals for therapy of herpesvirus diseases.
    Merigan TC
    Dev Biol Stand; 1982; 52():527-33. PubMed ID: 6187616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpesvirus infection: an overview of the clinical manifestations.
    Peterslund NA
    Scand J Infect Dis Suppl; 1991; 80():15-20. PubMed ID: 1666443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesviruses and the microbiome.
    Dreyfus DH
    J Allergy Clin Immunol; 2013 Dec; 132(6):1278-86. PubMed ID: 23611298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis due to herpes group viruses].
    Cisneros-Herreros JM; Herrero-Romero M
    Enferm Infecc Microbiol Clin; 2006; 24(6):392-7; quiz 398. PubMed ID: 16792943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 118.